Cytokine-inducing activity of a proline-rich polypeptide complex (PRP) from ovine colostrum and its active...

Area of Science:

• Immunology
• Biochemistry
• Peptide Science

Background:

• Proline-rich polypeptides (PRP) from ovine colostrum exhibit immunomodulatory and psychotropic properties, with potential therapeutic applications in Alzheimer's disease.
• Specific peptide fragments, a nonapeptide (NP) and a hexapeptide (HP), derived from PRP, possess immunoregulatory activity but show reduced cytokine-inducing capacity compared to the parent PRP complex.
• The need for more potent immunomodulatory agents necessitates investigation into the structure-activity relationships of PRP fragments and their oligomers.

Purpose of the Study:

• To compare the cytokine-inducing abilities of the intact PRP complex, monomeric NP and HP peptides, and their linear oligomers.
• To investigate the dose-dependent effects of these peptides on the induction of key cytokines, including Interferon (IFN), Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-6 (IL-6), and Interleukin-10 (IL-10).
• To identify specific peptide structures that can effectively induce cytokines, potentially serving as alternatives to the native PRP complex.

Main Methods:

• Isolation and preparation of proline-rich polypeptides (PRP), nonapeptide (NP), hexapeptide (HP), and their linear oligomers.
• Incubation of human whole blood cell cultures with varying concentrations of PRP, NP, HP, and their oligomers.
• Quantification of induced cytokines (IFN, TNF-alpha, IL-6, IL-10) using appropriate assays.

Main Results:

• PRP complex demonstrated a regulatory, bell-shaped dose-response curve for cytokine induction.
• Monomeric NP and HP peptides, along with their oligomers, generally exhibited lower cytokine-inducing activity than PRP.
• Specific hexapeptide oligomers (HP3, HP4) showed significantly enhanced induction of Th2 cytokines (IL-6, IL-10) compared to monomeric forms and NP peptides, with HP4 activity approaching that of lipopolysaccharide-phytohemagglutinin (LPS-PHA).

Conclusions:

• Certain peptide oligomers, particularly HP3 and HP4, can effectively induce specific cytokines, especially Th2 cytokines like IL-10, at higher concentrations.
• These oligomers may serve as potent and selective cytokine inducers, potentially replacing the native PRP complex in certain applications.
• The study highlights the potential for developing targeted immunomodulatory therapies based on specific peptide structures and their oligomerization states.